CD80 and cancer: The results showed that the basal expression of the CD80, CD86 and HLA-DR molecules in monocytes, myeloid dendritic cells (mDCs) and plasmacytoid dendritic cells (pDCs) was largely comparable between healthy subjects and cancer patients, before and after the chemotherapy.